King-Mylan deal said &#39;extremely risky&#39;
543076
Financier Carl Icahn said Monday King Pharmaceutical Inc.&#39;s possible need to restate earnings reinforces his belief that an acquisition of King by Mylan Laboratories Inc.
210669
Mylan Laboratories Inc. MYL.N on  Wednesday said investor Carl Icahn's opposition to Mylan's  proposed purchase of King Pharmaceuticals Inc. KG.N does not  affect Mylan's commitment to complete the transaction.
603432
PITTSBURGH The chief executive of Mylan Laboratories says a move by Wall Street financier Carl Icahn (EYE&#39;-kahn) to halt Mylan&#39;s acquisition of King Pharmaceuticals is wrongheaded.
550625
Financier Carl Icahn on Friday  offered to buy the shares of generic drugmaker Mylan  Laboratories MYL.N that he does not already own for $4.9  billion, or $20 a share, according to a government filing.
165725
A large Lockheed Martin   contract to build a fleet of helicopters for the president  could be in trouble, the Wall Street Journal said on Friday,  citing people familiar with the situation.
321927
Mylan Laboratories&#39; (MYL:NYSE - news - research) board of directors Monday once again rejected investor Carl Icahn&#39;s takeover offer while also questioning his intentions and said it planned to go ahead with its planned acquisition of King Pharmaceuticals
84238
Mylan Laboratories Inc. MYL.N on  Friday said its board of directors remains committed to the  purchase of King Pharmaceuticals Inc. KG.N, despite news that  billionaire investor Carl Icahn won regulatory approval to buy  up to 11.9 percent of Mylan's shares.
303450
OK, maybe after today&#39;s announcement, and Justin King&#39;s Â£400 million revival plan for the struggling supermarket chain, it is hard to vindicate the decisions of his predecessor.
639540
PITTSBURGH Carl Icahn, the largest shareholder of Mylan Laboratories, is now threatening to push for new company directors to stop the generic drug maker&#39;s four (B) billion-dollar takeover bid of King Pharmaceuticals.
759454
Slot manufacturer gets pummeled after releasing profit warning.
755767
Mylan Laboratories Inc.'s MYL.N board  on Monday rebuffed financier Carl Icahn's bid to buy the  company, and said it remains committed to its $3.37 billion  purchase of brand-name drug-maker King Pharmaceuticals Inc.  KG.N.
344285
A high-profile promotion proves as risky as it is bungled.
191627
Check--or checkmate? Carl Icahn, attempting to block Mylan Laboratories (nyse: MYL - news - people ) in its buyup of King Pharmaceuticals (nyse: KG - news - people ), made his move: Earlier this month, the
743157
Without citing specific sources, the Sunday newspaper said Citigroup&#39;s price could exceed Lehman&#39;s offer, put by sources at 500 million pounds up front, but would likely fall short of the 1 billion pounds-plus sought by Cazenove.
386076
In a letter to the board of directors at Mylan Laboratories (nyse: MYL - news - people ), financier Carl Icahn questioned their silence on the recent financial restatements by King Pharmaceuticals (nyse: KG - news - people ), calling the &quot;lack of
406523
UBS Global Asset Management told Mylan Laboratories Inc. that Mylan&#39;s proposed acquisition of King Pharmaceuticals Inc. is dilutive to Mylan shareholders and not in the best interests of the investment firm&#39;s
723851
Generic drug maker Mylan Laboratories Inc.  said on Friday it expects to raise $993.6 million, following a pricing of its public offerings of notes and shares.